[1] Loh K P, Huang S H, De Silva R, et al. Oxidative stress: apoptosis in neuronal injury[J]. Curr Alzheimer Res, 2006, 3(4):327-337.[2] Winner B, Desplats P, Hagl C, et al. Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model[J]. Exp Neurol, 2009, 219(2):543-552.[3] Ferrari-Toninelli G, Maccarinelli G, Uberti D, et al. Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole[J]. BMC Pharmacol, 2010, 10:2.[4] Wang H, Larriviere K S, Keller K E, et al. R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS[J]. Amyotroph Lateral Scler, 2008, 9(1):50-58.[5] 李森, 闫峰, 闫颖, 等.大鼠局灶性脑缺血损伤后半暗带区锌离子的变化[J].中国神经免疫学和神经病学杂志, 2012, 19(3):175-178.[6] 李芳, 刘向荣, 闫峰, 等.局部亚低温对大鼠脑缺血再灌注基质金属蛋白酶9及细胞外基质蛋白表达的影响[J].首都医科大学学报, 2013, 34(1):58-63.[7] Villa R F, Gorini A, Ferrari F, et al. Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes[J]. Neurochem Int, 2013, 63(8):765-781.[8] 韩冬, 孙淼, 张硕, 等.缺血后处理对大鼠脑缺血再灌注的神经保护作用[J].中国医科大学学报, 2012, 41(10):896-899.[9] 刘小蒙, 罗玉敏, 陈俊.缺血性脑血管病神经保护药转化医学的现状[J].中国脑血管病杂志, 2012, 9(10):208-212.[10] Li J, Yu W, Li X T, et al. The effects of propofol on mitochondrial dysfunction following focal cerebral ischemia-reperfusion in rats[J]. Neuropharmacology, 2014, 77:358-368.[11] 张红明, 曾子玲, 李晓燕.线粒体依赖的凋亡通路与缺血性脑卒中[J].中华老年心血管病杂志, 2013, 15(7):778-780.[12] Jian Liu K, Rosenberg G A. Matrix metalloproteinases and free radicals in cerebral ischemia[J]. Free Radic Biol Med, 2005, 39(1):71-80.[13] Sayeed I, Parvez S, Winkler-Stuck K, et al. Patch clamp reveals powerful blockade of the mitochondrial permeability transition pore by the D2-receptor agonist pramipexole[J]. FASEB J, 2006, 20(3):556-558.[14] Zou L, Xu J, Jankovic J, et al. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in C57BL/6 mice[J]. Neurosci Lett, 2000, 281(2-3):167-170.[15] Danzeisen R, Schwalenstoecker B, Gillardon F, et al. Targeted antioxidative and neuroprotective properties of the dopamine agonist pramipexole and its nondopaminergic enantiomer SND919CL2x[J]. J Pharmacol Exp Ther, 2006, 316(1):189-199.[16] Wani W Y, Sunkaria A, Sharma D R, et al. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation[J]. Neuroscience, 2014, 258:1-15.[17] Boscolo A, Starr J A, Sanchez V, et al. The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: the importance of free oxygen radicals and mitochondrial integrity[J]. Neurobiol Dis, 2012, 45(3):1031-1041. |